Market in consolidation mode ; triggers needed, says Sunil Subramaniam
Indian pharma stocks are rebounding, driven by domestic investors after a period of Foreign Institutional Investor (FII) selling pressure. Uncertainty surrounding potential US tariffs, fueled by Trump's statements and delays in the Bilateral Trade Agreement (BTA), had initially impacted the (...)
Site référencé: The Economic Times
The Economic Times
Indian equity indices surge 1% amid SBI profit boost and Trump-Putin meeting optimism
12/08/2025
PG Electroplast plummets 35% in 5 days amid weak revenue guidance
12/08/2025
SBI halts Nayara transactions over US tariffs, sanctions risk
11/08/2025
JM Financial Q1 profit jumps 166% to Rs 454 crore
11/08/2025
Kotak Mahindra MF, Citigroup, others buy 10.64% stake in Home First Finance for Rs 1,307 crore
11/08/2025
Gold retreats from all-time high, ends Rs 900 lower at Rs 1,02,520/10g
11/08/2025
